Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
19 Results for "
human neonatal Fc receptor
" in MedChemExpress (MCE) Product Catalog:
Products (19)
19 Results for "human neonatal Fc receptor" in MCE Product Catalog:
2
Target:
Research Areas:
1
1 Cited Publications
Cat. No.: HY-P70601
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: FcGRT; Major Histocompatibility Complex Class I-Like Fc receptor; Fc Gamma receptor And Transporter; neonatal Crystallizable Fc receptor FcRn Splice Variant 6; neonatal Fc receptor; neonatal Crystallizable Fc receptor FcRn Splice Variant 5; FcRn; neonatal
Species:
Human
Source:
HEK293
Cat. No.: HY-P990091
CAS No.: 2756228-76-7
Synonyms: SAR 445088
Target:
Research Areas:
Cat. No.: HY-P991055
CAS No.: 2649379-96-2
Synonyms: RG-6234; RO-7425781
Target:
Research Areas:
Cat. No.: HY-145775
CAS No.: 1425051-22-4
Target:
Research Areas:
hIgG-hFc receptor-IN-1 is a quinoxaline-based human immunoglobulin G-human neonatal Fc receptor (hIgG-hFcRn) protein-protein interaction inhibitor with an IC50 of 2 μM. hIgG-hFc receptor-IN-1 blocks the binding of hIgG to human FcRn. hIgG-hFc receptor-IN-1 can be used for immune-related research .
Cat. No.: HY-187394
CAS No.: 1425050-80-1
Target:
Research Areas:
hIgG-hFc receptor-IN-3 is a protein-protein interaction inhibitor of human immunoglobulin G-human neonatal Fc receptor (hIgG-hFcRn). Identified via virtual ligand screening and optimized through structure-activity relationship studies, hIgG-hFc receptor-IN-3 competitively inhibits the binding of IgG to FcRn, thereby accelerating the clearance of endogenous IgG. hIgG-hFc receptor-IN-3 can be used for the research of autoimmune diseases .
Cat. No.: HY-P11882
CAS No.: 947545-69-9
Target:
Research Areas:
Cat. No.: HY-P11786
CAS No.: 1020264-43-0
Target:
Research Areas:
SYN1327 is a potent monomeric cyclic competitive antagonistic peptide targeting the neonatal Fc receptor (FcRn), with a Kd of 31 nM for human FcRn at pH 6 and a Kd of 170 nM at pH 7.4. SYN1327 competitively binds to the IgG-binding site of FcRn and inhibits the binding of human IgG to FcRn. SYN1327 acts as the monomeric precursor of the dimeric peptide SYN1436 (HY-P11882). SYN1327 can be used in studies related to IgG-mediated autoimmune diseases .
Cat. No.: HY-P11786A
Target:
Research Areas:
SYN1327 acetate is a potent monomeric cyclic competitive antagonistic peptide targeting the neonatal Fc receptor (FcRn), with a Kd of 31 nM for human FcRn at pH 6 and a Kd of 170 nM at pH 7.4. SYN1327 acetate competitively binds to the IgG-binding site of FcRn and inhibits the binding of human IgG to FcRn. SYN1327 acetate acts as the monomeric precursor of the dimeric peptide SYN1436 (HY-P11882). SYN1327 acetate can be used in studies related to IgG-mediated autoimmune diseases .
Cat. No.: HY-P72192
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: FcGRT; Major Histocompatibility Complex Class I-Like Fc receptor; Fc Gamma receptor And Transporter; neonatal Crystallizable Fc receptor FcRn Splice Variant 6; neonatal Fc receptor; neonatal Crystallizable Fc receptor FcRn Splice Variant 5; FcRn; neonatal
Species:
Human
Source:
E. coli
Cat. No.: HY-P705914
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: FcGRT; Major Histocompatibility Complex Class I-Like Fc receptor; Fc Gamma receptor And Transporter; neonatal Crystallizable Fc receptor FcRn Splice Variant 6; neonatal Fc receptor; neonatal Crystallizable Fc receptor FcRn Splice Variant 5; FcRn; neonatal
Species:
Human
Source:
E. coli
Cat. No.: HY-P71664
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: FcGRT; Major Histocompatibility Complex Class I-Like Fc receptor; Fc Gamma receptor And Transporter; neonatal Crystallizable Fc receptor FcRn Splice Variant 6; neonatal Fc receptor; neonatal Crystallizable Fc receptor FcRn Splice Variant 5; FcRn; neonatal
Species:
Human
Source:
HEK293
Cat. No.: HY-P73522
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: FcGRT; Major Histocompatibility Complex Class I-Like Fc receptor; Fc Gamma receptor And Transporter; neonatal Crystallizable Fc receptor FcRn Splice Variant 6; neonatal Fc receptor; neonatal Crystallizable Fc receptor FcRn Splice Variant 5; FcRn; neonatal
Species:
Human
Source:
HEK293
Cat. No.: HY-P704603
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: FcGRT; Major Histocompatibility Complex Class I-Like Fc receptor; Fc Gamma receptor And Transporter; neonatal Crystallizable Fc receptor FcRn Splice Variant 6; neonatal Fc receptor; neonatal Crystallizable Fc receptor FcRn Splice Variant 5; FcRn; neonatal
Species:
Human
Source:
HEK293
Cat. No.: HY-P705300
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: FcGRT; Major Histocompatibility Complex Class I-Like Fc receptor; Fc Gamma receptor And Transporter; neonatal Crystallizable Fc receptor FcRn Splice Variant 6; neonatal Fc receptor; neonatal Crystallizable Fc receptor FcRn Splice Variant 5; FcRn; neonatal
Species:
Human
Source:
HEK293
Cat. No.: HY-P12128
Target:
Research Areas:
SYN1753 is a selective inhibitor of human neonatal Fc receptor (hFcRn) with a Kd value of 0.5 μM. SYN1753 binds to the albumin-binding site of hFcRn, inhibits the hFcRn-albumin interaction, and thereby suppresses FcRn-mediated transcytosis of human albumin. SYN1753 can be used in studies related to acetaminophen-induced liver injury .
Cat. No.: HY-P72368
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: FcGRT; Major Histocompatibility Complex Class I-Like Fc receptor; Fc Gamma receptor And Transporter; neonatal Crystallizable Fc receptor FcRn Splice Variant 6; neonatal Fc receptor; neonatal Crystallizable Fc receptor FcRn Splice Variant 5; FcRn; neonatal Fragment Crystallizable Fc receptor FcRn; IgG Fc Fragment receptor Transporter Alpha Chain; Immunoglobulin receptor, Intestinal, Heavy Chain; IgG receptor FcRn Large Subunit P51; neonatal Fc-receptor For Ig; FcgammaRn; FcRN Alpha-Chain; Heavy Chain Of The Major Histocompatibility Complex Class I-Like Fc receptor; FcRn Alpha Chain; Transmembrane Alpha Chain Of The neonatal receptor; Alpha-Chain; Fc Fragment Of IgG, receptor, Transporter, Alpha; FcRN; Fc Fragment Of IgG receptor And Transporter; B2M; Beta 2-Microglobulin; Beta-2-Microglobulin; Beta-2-Microglobin; Beta Chain Of MHC Class I Molecules; AMYLD6; Beta 2-Microglobulin Protein; MHC1D4; human Nkt Tcr Alpha Chain; IMD43; human Nkt Tcr Beta Chain
Species:
Human
Source:
HEK293
Cat. No.: HY-187393
CAS No.: 1425051-06-4
Target:
Research Areas:
hIgG-hFc receptor-IN-2 is a hFcRn inhibitor with an IC50 of 6 μM for human hFcRn. hIgG-hFc receptor-IN-2 blocks the protein-protein interaction between human IgG and the soluble extracellular domain of hFcRn. hIgG-hFc receptor-IN-2 serves as a tool for studying FcRn biology and a starting point for developing orally available small molecule hFcRn inhibitors. hIgG-hFc receptor-IN-2 can be used for the research of autoimmune disease .
Cat. No.: HY-182476
CAS No.: 1359344-58-3
Target:
Research Areas:
Z223-2027 is a FcRn inhibitor. Z223-2027 competitively blocks the binding of immunoglobulin G (IgG) to FcRn. Z223-2027 can be used in the research of IgG-mediated autoimmune diseases .
- 1
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
